Product NDC: | 0904-6271 |
Proprietary Name: | Ziprasidone Hydrochloride |
Non Proprietary Name: | Ziprasidone Hydrochloride |
Active Ingredient(s): | 60 mg/1 & nbsp; Ziprasidone Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0904-6271 |
Labeler Name: | Major Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077565 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120315 |
Package NDC: | 0904-6271-08 |
Package Description: | 40 CAPSULE in 1 BOX, UNIT-DOSE (0904-6271-08) |
NDC Code | 0904-6271-08 |
Proprietary Name | Ziprasidone Hydrochloride |
Package Description | 40 CAPSULE in 1 BOX, UNIT-DOSE (0904-6271-08) |
Product NDC | 0904-6271 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ziprasidone Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120315 |
Marketing Category Name | ANDA |
Labeler Name | Major Pharmaceuticals |
Substance Name | ZIPRASIDONE HYDROCHLORIDE |
Strength Number | 60 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Atypical Antipsychotic [EPC],Atypical Antipsychotic [EPC] |